FI900641A0 - Indolderivat. - Google Patents

Indolderivat.

Info

Publication number
FI900641A0
FI900641A0 FI900641A FI900641A FI900641A0 FI 900641 A0 FI900641 A0 FI 900641A0 FI 900641 A FI900641 A FI 900641A FI 900641 A FI900641 A FI 900641A FI 900641 A0 FI900641 A0 FI 900641A0
Authority
FI
Finland
Prior art keywords
compounds
disclosed
group
headache
migraine
Prior art date
Application number
FI900641A
Other languages
English (en)
Finnish (fi)
Inventor
Peter Charles North
Martin Redpath Johnson
Alexander William Oxford
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI900641A0 publication Critical patent/FI900641A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI900641A 1989-02-10 1990-02-09 Indolderivat. FI900641A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898903036A GB8903036D0 (en) 1989-02-10 1989-02-10 Chemical compounds

Publications (1)

Publication Number Publication Date
FI900641A0 true FI900641A0 (fi) 1990-02-09

Family

ID=10651482

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900641A FI900641A0 (fi) 1989-02-10 1990-02-09 Indolderivat.

Country Status (16)

Country Link
US (1) US5001135A (de)
EP (1) EP0382570B1 (de)
JP (1) JP2941333B2 (de)
KR (1) KR900012925A (de)
CN (1) CN1058778A (de)
AT (1) ATE98230T1 (de)
AU (1) AU4931590A (de)
CA (1) CA2009745A1 (de)
DE (1) DE69004989T2 (de)
FI (1) FI900641A0 (de)
GB (1) GB8903036D0 (de)
IL (1) IL93337A0 (de)
NO (1) NO900636L (de)
NZ (1) NZ232449A (de)
PT (1) PT93112A (de)
ZA (1) ZA90974B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE92057T1 (de) * 1987-08-13 1993-08-15 Glaxo Group Ltd Indol-derivate.
DK733788A (da) * 1988-01-14 1989-07-15 Fujisawa Pharmaceutical Co Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
GB9320115D0 (en) * 1993-09-29 1993-11-17 Glaxo Group Ltd Process
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
AU702322B2 (en) * 1995-03-20 1999-02-18 Eli Lilly And Company 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2183235A (en) * 1935-03-08 1939-12-12 Ici Ltd Automatic control of variable physical characteristics
US3409626A (en) * 1963-09-17 1968-11-05 Neisler Lab Inc Indolylethyl pyridinium quaternary ammonium compounds
US3238215A (en) * 1963-10-17 1966-03-01 Sterling Drug Inc 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines
US3217811A (en) * 1964-12-16 1965-11-16 United Aircraft Corp Rotor head fairing for high speed vehicle
GB1410783A (en) * 1972-01-20 1975-10-22 Wyeth John & Brother Ltd N-substituted 4-amidopyridines tetrahydropyridines and piperidines
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
BE903778A (fr) * 1984-12-04 1986-06-03 Glaxo Group Ltd Derives d'indoles.
DE3518300A1 (de) * 1985-05-22 1986-11-27 Horst E. 7240 Horb Dreier Schaltgeraet fuer rechnergesteuerte werkzeugmaschinen und messanordnung unter dessen verwendung
GB8601959D0 (en) * 1986-01-28 1986-03-05 Glaxo Group Ltd Indole derivatives
ATE92057T1 (de) * 1987-08-13 1993-08-15 Glaxo Group Ltd Indol-derivate.

Also Published As

Publication number Publication date
GB8903036D0 (en) 1989-03-30
NO900636L (no) 1990-08-13
ATE98230T1 (de) 1993-12-15
KR900012925A (ko) 1990-09-03
DE69004989T2 (de) 1994-03-24
EP0382570A1 (de) 1990-08-16
DE69004989D1 (de) 1994-01-20
PT93112A (pt) 1990-08-31
NZ232449A (en) 1991-07-26
EP0382570B1 (de) 1993-12-08
AU4931590A (en) 1990-08-16
JP2941333B2 (ja) 1999-08-25
NO900636D0 (no) 1990-02-09
US5001135A (en) 1991-03-19
CN1058778A (zh) 1992-02-19
IL93337A0 (en) 1990-11-29
ZA90974B (en) 1991-10-30
CA2009745A1 (en) 1990-08-10
JPH02300184A (ja) 1990-12-12

Similar Documents

Publication Publication Date Title
NO1998008I1 (no) Naratriptan
FI893751A (fi) Kemiska foereningar.
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
ATE98230T1 (de) Indolderivate.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: GLAXO GROUP LIMITED